Paul Wilson and Aarthi Rao
This work was supported by a grant from the Bill and Melinda Gates Foundation
Results for Development Institute. R4D – 2012
Available online PDF [96p.] at: http://bit.ly/ObZcyW
To reduce this burden,
For example, there are no vaccines against malaria or dengue fever and no cheap and accurate point-of care tests for tuberculosis.
India already manufacturers most of the drugs, vaccines, and diagnostic tests it uses and has established itself as an important supplier of affordable drugs and vaccines to other developing countries. In most cases, these products were first developed by scientists and companies in high-income countries, but India’s capacity for innovation—and that of other rapidly developing countries, such as China and Brazil—is growing.
To what extent can
Are for-profit Indian firms more likely to invest in products for neglected diseases than are the established multinational companies based in high-income countries? What are the main obstacles to neglected disease research and development (R&D) in
This report, based on interviews with policymakers, industry executives, and Indian and international experts, explores these questions. It surveys the landscape of neglected diseases R&D in
2. The Supporting Environment for Biomedical Innovation
6. Conclusions and Recommendations
Annex I: Government Initiatives to Support Pharmaceutical and Biotechnology R&D
Annex II: Government Agencies Involved in the Regulation of Health Technologies in
Annex III: People Interviewed
* * *
This message from the Pan American Health Organization, PAHO/WHO, is part of an effort to disseminate
information Related to: Equity; Health inequality; Socioeconomic inequality in health; Socioeconomic
health differentials; Gender; Violence; Poverty; Health Economics; Health Legislation; Ethnicity; Ethics;
Information Technology - Virtual libraries; Research & Science issues. [DD/ KMC Area]
“Materials provided in this electronic list are provided "as is". Unless expressly stated otherwise, the findings
and interpretations included in the Materials are those of the authors and not necessarily of The Pan American
Health Organization PAHO/WHO or its country members”.
Equity List - Archives - Join/remove: http://listserv.paho.org/Archives/equidad.html
IMPORTANT: This transmission is for use by the intended
recipient and it may contain privileged, proprietary or
confidential information. If you are not the intended
recipient or a person responsible for delivering this
transmission to the intended recipient, you may not
disclose, copy or distribute this transmission or take
any action in reliance on it. If you received this transmission
in error, please dispose of and delete this transmission.